My Pitch: "FDA approval near!!!!"

My Pitch: "Pro genix pharma "

My Pitch: "oct4-14 14:00 PGNX 5.20
$11 price target -the company presented long-term follow-up data on the 41 pheochromocytoma patients treated with Azedra in its pivotal Phase 2 trial"

My Pitch: "I like the potential of this stock with their deep pipeline (9) if not mistaken. Great long term hold!!!"

My Pitch: "Bought into this after the big drop-off on November 12th.

The FDA officials now want a large and long-term safety study conducted before their constipation drug Relistor will be approved. Despite this, stock was selling at close to $10/share earlier this year and will rebound."

My Pitch: "New drug"

My Pitch: "Pgnx"